The Effects of Dopamine on Reward Processing
Phase 1
Completed
- Conditions
- Major Depressive Disorder (MDD)
- Interventions
- Drug: placebo
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2018-04-27
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 159
- Registration Number
- NCT01253421
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
Phase 4
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-06-23
- Last Posted Date
- 2017-05-23
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT01148979
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
Frovatriptan and Menstrual Migraine
Terminated
- Conditions
- FrovatriptanMenstrual Migraine
- First Posted Date
- 2010-05-03
- Last Posted Date
- 2018-04-12
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT01114711
- Locations
- 🇺🇸
Neuroimaging Center, McLean Hospital, Belmont, Massachusetts, United States
Treximet Migraine Brain Imaging Research Study
Terminated
- Conditions
- Acute Migraine
- First Posted Date
- 2010-04-28
- Last Posted Date
- 2012-11-01
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 2
- Registration Number
- NCT01112553
- Locations
- 🇺🇸
Neuroimaging Center, McLean Hospital, Belmont, Massachusetts, United States
Generalized Anxiety and Seroquel
Not Applicable
Terminated
- Conditions
- Generalized Anxiety DisorderSeroquel XR
- Interventions
- First Posted Date
- 2010-02-10
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 8
- Registration Number
- NCT01066143
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
Not Applicable
Completed
- Conditions
- Bulimia NervosaBody Dysmorphic Disorder
- Interventions
- First Posted Date
- 2009-12-23
- Last Posted Date
- 2015-05-04
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT01038128
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
Puerarin Effects on Alcohol Drinking
Phase 2
Completed
- Conditions
- Alcohol Abuse
- Interventions
- Drug: Puerarin, Placebo
- First Posted Date
- 2009-03-03
- Last Posted Date
- 2011-09-09
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT00854724
- Locations
- 🇺🇸
McLean Hospital, Behavioral Psychopharmacology Research Laboratory, Belmont, Massachusetts, United States
Cytidine and Omega-3 Fatty Acids in Bipolar Disorder
Phase 2
Completed
- Conditions
- Bipolar Disorder
- Interventions
- Dietary Supplement: cytidineDrug: placeboDietary Supplement: omega-3 fatty acids
- First Posted Date
- 2009-03-03
- Last Posted Date
- 2012-04-20
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT00854737
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
🇺🇸Jersey Shore University Medical Center, Neptune, New Jersey, United States
Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation
Not Applicable
Withdrawn
- Conditions
- Bipolar DisorderSchizophreniaHealthy Controls
- Interventions
- Device: Magnetic resonance spectroscopy (MRS)
- First Posted Date
- 2008-12-03
- Last Posted Date
- 2012-03-12
- Lead Sponsor
- Mclean Hospital
- Registration Number
- NCT00801567
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
Follow-Up Extension to the Family Study of Binge Eating Disorder
Completed
- Conditions
- Binge Eating Disorder
- Interventions
- Other: No intervention.
- First Posted Date
- 2008-10-22
- Last Posted Date
- 2012-05-29
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 268
- Registration Number
- NCT00777634
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath